Thore Hettmann
11Patents
3h-index
19Co-inventors
53Inventor score
Filing activity: Sep 26, 2008 → May 9, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10383878B2 | Anti-HER3 antibody-drug conjugate | Chemistry; Metallurgy | 26 | Active |
| US8933202B2 | AXL antibodies | Chemistry; Metallurgy | 6 | Active |
| US9101760B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 6 | Active |
| US9803025B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 3 | Active |
| US9988462B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 2 | Active |
| US10357566B2 | HER3 inhibitor for modulating radiosensitivity | Chemistry; Metallurgy | 1 | Active |
| US11351259B2 | HER3 inhibitor for modulating radiosensitivity | Chemistry; Metallurgy | 0 | Active |
| US11298359B2 | Anti-HER3 antibody-drug conjugate | Chemistry; Metallurgy | 0 | Active |
| US8828382B2 | Heparin-binding epidermal growth factor-like growth factor binding proteins | Chemistry; Metallurgy | 0 | Active |
| US12043659B2 | Humanized and de-immunized antibodies | Chemistry; Metallurgy | 0 | Active |
| US12139549B2 | Material and methods for treating or preventing HER-3 associated diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.